Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group

BACKGROUND: Only a minority of prostate cancer patients with adverse pathology and biochemical recurrence (BCR) post radical prostatectomy (RP) experience metastasis and die from prostate cancer. Improved risk prediction models using genomic information may enable clinicians to better weigh the risk...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Badani, Ketan, Thompson, Darby J. S., Buerki, Christine, Davicioni, Elai, Garrison, Jill, Ghadessi, Mercedeh, Mitra, Anirban P., Wood, Penelope J., Hornberger, John
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2013
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3720607/
https://ncbi.nlm.nih.gov/pubmed/23592338
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares